KR960000242A - Radix extract inhibiting the production of interleukin-6 and its preparation method - Google Patents

Radix extract inhibiting the production of interleukin-6 and its preparation method Download PDF

Info

Publication number
KR960000242A
KR960000242A KR1019950011641A KR19950011641A KR960000242A KR 960000242 A KR960000242 A KR 960000242A KR 1019950011641 A KR1019950011641 A KR 1019950011641A KR 19950011641 A KR19950011641 A KR 19950011641A KR 960000242 A KR960000242 A KR 960000242A
Authority
KR
South Korea
Prior art keywords
hours
extract
root
methanol
root extract
Prior art date
Application number
KR1019950011641A
Other languages
Korean (ko)
Other versions
KR0161145B1 (en
Inventor
변광호
최인표
강형식
이정준
김영호
Original Assignee
김은영
한국과학기술연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김은영, 한국과학기술연구원 filed Critical 김은영
Priority to KR1019950011641A priority Critical patent/KR0161145B1/en
Publication of KR960000242A publication Critical patent/KR960000242A/en
Application granted granted Critical
Publication of KR0161145B1 publication Critical patent/KR0161145B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/59Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Abstract

본 발명은 분방기(Stephania tetrandra S. Moore)의 뿌리에서 분리한 여러가지 추출물(extract), 이들의 제조 방법 및 이를 포함하는 약학적 조성물에 관한 것으로서, 이들을 이용하여 인체의 면역체계를 조절하는 중요한 인자인 인터루킨-6(interleukin-6, IL-6)의 생산을 조절함으로서 인터루킨-6 생산량과 관련있는 콜라겐 생산, 반응성 산소 생산 및 관절염 환자의 활막세포(synoviocyte)의 세포성장을 효과적으로 조절하여 이로 인한 질병을 치료할 수 있다.The present invention relates to various extracts isolated from the roots of Stephania tetrandra S. Moore, methods for their preparation, and pharmaceutical compositions comprising the same, which are important factors for regulating the immune system of the human body using them. By regulating the production of interleukin-6 (IL-6), it effectively regulates collagen production, reactive oxygen production, and cell growth of synoviocytes in patients with arthritis. Can cure.

Description

인터루킨-6의 생산을 억제하는 분방기 추출물 및 그의 제조방법Radix extract inhibiting the production of interleukin-6 and its preparation method

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

제1도는 분방기 추출물 A 및 B의 세포독성 검정결과를 나타내고,Figure 1 shows the cytotoxicity assay results of the extracts A and B

제2도는 분방기 추출물 A 및 B에 의한 사람 단핵구/대식세포의 인터루킨-6 생산억제 효과를 측정한 결과를 나타내고,Figure 2 shows the results of measuring the inhibitory effect of interleukin-6 production of human monocytes / macrophages by the secretory extract A and B,

제3도는 분방기 추출물 A에 의한 흰쥐 폐 대식세포의 인터루킨-6 생산 억제 효과를 측정한 결과를 나타낸다.Figure 3 shows the results of measuring the inhibitory effect of interleukin-6 production of rat lung macrophages by the secretion extract A.

Claims (15)

인터루킨-6의 생산을 억제함으로써 인터루킨-6 과잉 생산으로 인한 면역질환의 치료에 유용한, 분방기(Stephania tetrandra S. Moore) 뿌리 추출물.Stephania tetrandra S. Moore root extract, useful for the treatment of immune diseases caused by interleukin-6 overproduction by inhibiting the production of interleukin-6. 제1항에 있어서, 메탄올에 의한 추출물; 에탄올에 의한 추출물, CH2CI2에 의한 추출물; 또는 수용액에 의한 추출물인 분방기 뿌리 추출물.The method of claim 1, further comprising extracts with methanol; Extract with ethanol, extract with CH 2 CI 2 ; Or Bungigi root extract, which is an extract by an aqueous solution. 제2항에 있어서, 건조된 분방기 뿌리 1㎏ 중량당 1 내지 3ℓ의 메탄올을 가하여 50 내지 70℃에서 4시간 이상 추출하는 단계를 포함하는 방법에 의해 제조된 분방기 뿌리 추출물.The method according to claim 2, wherein 1 to 3 liters of methanol per kilogram of dried spinneret root is added to extract the spinneret root extract prepared by the method comprising extracting at 50 to 70 ℃ for at least 4 hours. 제2항에 있어서, 제3항에 따른 뿌리 추출물을 100g당 200 내지 400㎖의 메탄올과 200 내지 400㎖의 n-헥산으로 분획하여 메탄올층을 얻은 후 감압농축하여 메탄올을 제거하고, 수산화암모늄 또는 수산화나트륨으로 pH를 9 내지 11로 조절한 다음 400 내지 800㎖의 증류수:CH2CI2(1:1(v/v))로 분획하여 CH2CI2층을 분리하는 단계를 포함하는 방법에 의해 제조된 분방기 뿌리 추출물.The method of claim 2, wherein the root extract according to claim 3 is fractionated into 200 to 400 ml of methanol and 200 to 400 ml of n-hexane per 100 g to obtain a methanol layer, and then concentrated under reduced pressure to remove methanol, ammonium hydroxide or Adjusting the pH to 9-11 with sodium hydroxide and then fractionating 400-800 mL of distilled water: CH 2 CI 2 (1: 1 (v / v)) to separate the CH 2 CI 2 layer. Radix root extract prepared by. 제2항에 있어서, 건조된 분방기 뿌리를 파쇄하여 여과한 후 멸균된 증류수 또는 생리식염수 등의 수용액으로 50 내지 200㎎/㎖의 농도가 되도록 현탁한 다음 80 내지 100℃에서 4 내지 12시간 동안 중탕하는 단계를 포함하는 방법에 의해 제조된 분방기 뿌리 추출물.The method of claim 2, wherein the dried spinneret roots are crushed and filtered, and then suspended in an aqueous solution such as sterilized distilled water or physiological saline to a concentration of 50 to 200 mg / ml, followed by 4 to 12 hours at 80 to 100 ° C. Bunbang root extract prepared by the method comprising the step of boiling water. 제2항에 있어서, 건조된 분방기 뿌리 1㎏ 중량당 1 내지 3ℓ의 증류수를 가하여 80 내지 100℃로 4 내지 12시간 동안 가열한 후 여과하고 감압농축시킨 다음, -70 내지 -90℃에서 2 내지 10시간 동안 방치하고 4 내지 8시간 동안 동결건조시키는 단계를 포함하는 방법에 의해 제조된 분방기 뿌리 추출물.The method according to claim 2, wherein 1 to 3 liters of distilled water is added per 1 kg of dried spinner roots, heated to 80 to 100 ° C. for 4 to 12 hours, filtered and concentrated under reduced pressure, followed by 2 at -70 to -90 ° C. Spinach root extract prepared by the method comprising the step of leaving for 10 to 10 hours and lyophilized for 4 to 8 hours. 제2항에 있어서, 건조된 분방기 뿌리 1㎏ 중량당 1 내지 3ℓ의 에탄올을 가하여 60 내지 90℃에서 4시간 이상 추출하는 단계를 포함하는 방법에 의해 제조된 분방기 뿌리 추출물.The method according to claim 2, wherein 1 to 3 L of ethanol per 1 kg of dried powdered roots is added to extract the powdered roots prepared by the method comprising extracting at 60 to 90 ° C. for at least 4 hours. 제1항에 있어서, 콜라겐 합성, 반응성 산소 생산, 관절염 활막세포의 증식, 혈청 GOT 및 GPT의 증가와 관련된 질환의 치료에 유용한 분방기 뿌리 추출물.The branched root extract of claim 1, useful for the treatment of diseases associated with collagen synthesis, reactive oxygen production, proliferation of arthritis synovial cells, and an increase in serum GOT and GPT. 제8항에 있어서, 상기 질환의 류마티스 관절염, 간경변, 건선 피부병, 다발성 골수종, 카디악 믹소마, 규폐증 또는 에이즈(AIDS)인 분방기 뿌리 추출물.The method according to claim 8, which is rheumatoid arthritis, cirrhosis, psoriasis dermatosis, multiple myeloma, cardiac myxoma, silicosis or AIDS of said disease. 건조된 분방기 뿌리 1㎏ 중량당 1 내지 3ℓ의 메탄올을 가하여 50 내지 70℃에서 4시간 이상 추출하는 단계를 포함하는 메탄올에 의한 분방기 뿌리 추출물의 제조방법.1 to 3 L of methanol per 1 kg of weight of dried spinneret root, and extracting at least 50 hours at 50-70 ° C. 제10항에 따른 뿌리 추출물을 100g당 200 내지 400㎖의 메탄올과 200 내지 400㎖의 n-헥산으로 분획하여 메탄올층을 얻은 후 감압농축하여 메탄올을 제거하고, 수산화암모늄 또는 수산화나트륨으로 pH를 9 내지 11로 조절한 다음 400 내지 800㎖의 증류수:CH2CI2(1:1(v/v))로 분획하여 CH2CI2층을 분리하는 단계를 포함하는, 알칼로이드 분획 분방기 뿌리 추출물의 제조방법.The root extract according to claim 10 was fractionated into 200 to 400 ml of methanol and 200 to 400 ml of n-hexane per 100 g to obtain a methanol layer, and then concentrated under reduced pressure to remove methanol, and the pH was adjusted to 9 with ammonium hydroxide or sodium hydroxide. To an alkaloid fraction of the root extract extract comprising the step of adjusting to 11 to 400 to 800 mL of distilled water: CH 2 CI 2 (1: 1 (v / v)) to separate the CH 2 CI 2 layer Manufacturing method. 건조된 분방기 뿌리 1㎏을 파쇄하여 여과한 후 50 내지 200㎎/㎖의 농도가 되도록 수용액에 현탁한 다음 80 내지 100℃에서 4 내지 12시간 동안 중탕하는 단계를 포함하는 수용액에 의한 분방기 뿌리 추출물의 제조방법.1 kg of dried spinneret roots, crushed and filtered, suspended in an aqueous solution to a concentration of 50 to 200mg / ml, and then sprayed for 4-12 hours at 80-100 ° C Method of Preparation of Extracts. 건조된 분방기 뿌리 1㎏ 중량당 1 내지 3ℓ의 증류수를 가하여 80 내지 100℃로 4 내지 12시간 동안 가열한 후 여과하고 감압농축시킨 다음, -70 내지 -90℃에서 2 내지 10시간 동안 방치하고 4 내지 8시간 동안 동결건조시키는 단계를 포함하는 분말상의 뿌리 추출물의 제조방법.1 to 3 liters of distilled water per 1 kg of dried spinneret root was added, heated to 80 to 100 ° C. for 4 to 12 hours, filtered and concentrated under reduced pressure, and then left at -70 to -90 ° C. for 2 to 10 hours. Method for producing a powdered root extract comprising the step of lyophilization for 4 to 8 hours. 건조된 분방기 뿌리 1㎏ 중량당 1 내지 3ℓ의 에탄올을 가하여 60 내지 90℃에서 4시간 이상 추출하는 단계를 포함하는, 에탄올에 의한 분방기 뿌리 추출물의 제조방법.1 to 3 L of ethanol per 1 kg of weight of the dried spinneret root, and extracting at 60 to 90 ° C. for at least 4 hours. 제1항 내지 제9항중 어느 한 항의 분방기 뿌리 추출물을 유효량 포함하는, 인터루킨-6 과잉생산으로 인한 면역질환의 치료에 유용한 약학적 조성물.A pharmaceutical composition useful for the treatment of immune diseases caused by interleukin-6 overproduction, comprising an effective amount of the branched root extract of any one of claims 1 to 9. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950011641A 1994-06-09 1995-05-12 Extracts of stephania tetrandra for inhibition of interleukin-6 production KR0161145B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950011641A KR0161145B1 (en) 1994-06-09 1995-05-12 Extracts of stephania tetrandra for inhibition of interleukin-6 production

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR94-12962 1994-06-09
KR19940012962 1994-06-09
KR1019950011641A KR0161145B1 (en) 1994-06-09 1995-05-12 Extracts of stephania tetrandra for inhibition of interleukin-6 production

Publications (2)

Publication Number Publication Date
KR960000242A true KR960000242A (en) 1996-01-25
KR0161145B1 KR0161145B1 (en) 1998-12-01

Family

ID=19384977

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950011641A KR0161145B1 (en) 1994-06-09 1995-05-12 Extracts of stephania tetrandra for inhibition of interleukin-6 production

Country Status (5)

Country Link
EP (1) EP0759766A1 (en)
JP (1) JPH09506635A (en)
KR (1) KR0161145B1 (en)
CN (1) CN1150389A (en)
WO (1) WO1995033473A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100234611B1 (en) * 1996-03-21 1999-12-15 야나가와 히로미 Medicine administering device for nasal cavities

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162437A (en) * 1997-11-25 2000-12-19 Korea Institute Of Science & Technology Method for inhibiting interleukin-6 production by administering extracts from root of Stephania tetrandra
CN1217666C (en) * 1998-12-25 2005-09-07 东丽株式会社 Interleukin-6 production inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04159278A (en) * 1990-10-24 1992-06-02 Tsumura & Co New alkaloid and acetylcholine esterase inhibitor containing the same alkaloid as active ingredient

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100234611B1 (en) * 1996-03-21 1999-12-15 야나가와 히로미 Medicine administering device for nasal cavities

Also Published As

Publication number Publication date
KR0161145B1 (en) 1998-12-01
CN1150389A (en) 1997-05-21
WO1995033473A1 (en) 1995-12-14
EP0759766A1 (en) 1997-03-05
JPH09506635A (en) 1997-06-30

Similar Documents

Publication Publication Date Title
US8563054B2 (en) Anti-inflammatory agent
WO2011019239A2 (en) Composition containing a natural extract
KR20180110939A (en) Composition for preventing hair loss and promoting hair growth comprising plant extract
KR101367423B1 (en) Pharmaceutical composition and cosmetic compostion for improving skin condition and preparation method thereof
KR101192409B1 (en) Pharmaceutical compositions for preventing or treating inflammatory diseases using Trachelospermi caulis partitionated extract and its manufacture method
KR20210112570A (en) Tea composition for preventing, improving or treating respiratory disease and pharmaceutical composition including the same
KR100483539B1 (en) Composition for preventing or treating atopic dermatitis and process for preparation thereof
KR101851167B1 (en) Pharmaceutical composition containing extract of Spiraea prunifolia for prevention and treatment of allergic diease
KR101399925B1 (en) Process for preparing Vitis vinifera pip extract and pharmaceutical composition for preventing or treating rheumatoid arthritis comprising the same
KR960000242A (en) Radix extract inhibiting the production of interleukin-6 and its preparation method
Bhandirge et al. An overview on phytochemical and pharmacological profile of Cassia tora Linn
KR20040041912A (en) Anti-inflammatory composition containing paecilomyces extract and cordyceps extracts as effective composition
KR101023487B1 (en) Arthritis prevention or treatment composition comprising a mixed herbal extract of Schisandra chinensis, golden and thawed skin as an active ingredient
KR102262317B1 (en) Composition for anticancer or cancer supplement comprising root extract of Rhododendron mucronulatum
KR102261340B1 (en) A composition comprising extract of Prasiola japonica for preventing or treating for inflammatory skin diseases
WO2011108778A1 (en) Composite herbal preparation composition for dementia treatment and inhibition
KR102127771B1 (en) A composition for antioxidation, anti-inflammation, antiaging or skin soothing comprising herb complex extracts
CN1488355A (en) Cough-relieving chinese medicine formulation of total glycoside of mango leaf
WO2003094947A1 (en) Herbal extract for prophylaxis or treatment of inflammatory diseases and process for preparation thereof
GB2364640A (en) Composition for the treatment of peptic ulcer comprising American ginseng
CN109394801A (en) The composition of the decomposition of the generation and promotion glycosylation end products for inhibiting glycosylation end products containing chestnut Herba Visci extract
KR102302256B1 (en) A pharmaceutical composition for enhancing improvement effect of male sexual function or treatment effect of male infertility
KR20170051918A (en) Parmaceutical composition for treating or preventing arthritis comprising extract from roots of Anthriscus sylvestris
KR101884939B1 (en) Composition containing Lumbricus rubellus extract reducing lipid accumulation as effective component
JP3621483B2 (en) Histamine release inhibitor

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020807

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee